Cargando…
Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies
Percutaneous ablation is a mainstay of treatment for early stage, unresectable hepatocellular carcinoma (HCC). Recent advances in technology have created multiple ablative modalities for treatment of this common malignancy. The purpose of this review is to familiarize readers with the technical and...
Autores principales: | Huber, Timothy C, Bochnakova, Teodora, Koethe, Yilun, Park, Brian, Farsad, Khashayar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476177/ https://www.ncbi.nlm.nih.gov/pubmed/34589446 http://dx.doi.org/10.2147/JHC.S268300 |
Ejemplares similares
-
Essentials of Nutrition and Diet Therapy, 7(th) Ed
por: Farsad, Khashayar
Publicado: (1999) -
Comparative Vertebrate Neuroanatomy: Evolution and Adaptation
por: Farsad, Khashayar
Publicado: (1996) -
Liver-Directed Therapies for Hepatocellular Carcinoma and
Intrahepatic Cholangiocarcinoma
por: Kis, Bela, et al.
Publicado: (2017) -
Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020) -
Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
por: Viveiros, Pedro, et al.
Publicado: (2019)